Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Colon Cancer With Metastases to the Liver”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT03176485
What this trial is testing

Evaluation of Pathway Modulation by Raf, MEK, & Kinase Inhibitors

Who this might be right for
Metastatic CancerMelanomaColon Cancer+6 more
University of Arizona 45
Large-scale testing (Phase 3)Ended earlyNCT00023868
What this trial is testing

Combination Chemotherapy With or Without Chemoembolization in Treating Patients With Colorectal Cancer Metastatic to the Liver (6655)

Who this might be right for
Colorectal CancerMetastatic Cancer
American College of Radiology Imaging Network
Testing effectiveness (Phase 2)Study completedNCT00019760
What this trial is testing

Isolated Hepatic Perfusion With Melphalan Followed By Chemotherapy in Treating Patients With Unresectable Colorectal Cancer That is Metastatic to the Liver

Who this might be right for
Recurrent Colon CancerLiver MetastasesStage IV Rectal Cancer+2 more
National Institutes of Health Clinical Center (CC)
Testing effectiveness (Phase 2)Looking for participantsNCT02215889
What this trial is testing

Partial Liver Segment 2/3 Transplantation Study

Who this might be right for
Colorectal Cancer
Oslo University Hospital 20
Early research (Phase 1)UnknownNCT04660929
What this trial is testing

CAR-macrophages for the Treatment of HER2 Overexpressing Solid Tumors

Who this might be right for
HER2-positiveAdenocarcinomaBile Duct Cancer+28 more
Carisma Therapeutics Inc 48
Testing effectiveness (Phase 2)Active Not RecruitingNCT04595266
What this trial is testing

Chemoembolization (Lifepearls-Irinotecan) in Patients With Colorectal Cancer and Metastatic Disease

Who this might be right for
Colorectal Cancer MetastaticLiver Metastasis Colon Cancer
Grupo Espanol Multidisciplinario del Cancer Digestivo 48
Post-approval studies (Phase 4)Study completedNCT00764621
What this trial is testing

Health Economic Evaluation of Primovist-enhanced Liver MRI

Who this might be right for
Colorectal NeoplasmsNeoplasm Metastasis
Bayer 360
Testing effectiveness (Phase 2)Study completedNCT01186263
What this trial is testing

Predictive Value of 99mTc- Albumin Spheres Before 90Y- SIR Therapy

Who this might be right for
Colorectal CancerLiver Metastases
University of Magdeburg 24
Testing effectiveness (Phase 2)Study completedNCT00003834
What this trial is testing

Combination Chemotherapy in Treating Patients With Liver Metastases From Colorectal Cancer

Who this might be right for
Colorectal CancerMetastatic Cancer
Alliance for Clinical Trials in Oncology 44
Large-scale testing (Phase 3)Ended earlyNCT00268463
What this trial is testing

Oxaliplatin and Capecitabine With or Without an Hepatic Arterial Infusion With Floxuridine in Treating Patients Who Are Undergoing Surgery and/or Ablation for Liver Metastases Due to Colorectal Cancer

Who this might be right for
Colorectal CancerMetastatic Cancer
NSABP Foundation Inc 22
Early research (Phase 1)Study completedNCT00005842
What this trial is testing

Trastuzumab Plus R115777 in Treating Patients With Advanced or Metastatic Cancer

Who this might be right for
Cancer
National Cancer Institute (NCI) 24
Testing effectiveness (Phase 2)Study completedNCT00803647
What this trial is testing

A Study With Neoadjuvant mFOLFOX7 Plus Cetuximab to Determine the Surgical Conversion Rate for Unresectable Colorectal Cancer With Metastases Confined to the Liver

Who this might be right for
Metastatic Colorectal Cancer
NSABP Foundation Inc 20
Testing effectiveness (Phase 2)Study completedNCT00033748
What this trial is testing

Vaccine Therapy in Treating Patients With Colorectal Cancer Metastatic to the Liver

Who this might be right for
Colorectal CancerMetastatic Cancer
Alliance for Clinical Trials in Oncology 56
Large-scale testing (Phase 3)UnknownNCT00002692
What this trial is testing

Intravenous Compared With Intrahepatic Chemotherapy in Treating Patients With Colorectal Cancer Metastatic to the Liver

Who this might be right for
Colorectal CancerMetastatic Cancer
Medical Research Council 312
Testing effectiveness (Phase 2)Study completedNCT02380443
What this trial is testing

AlloStim® Immunotherapy Dosing Alone or in Combination With Cryoablation in Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer Metastatic
Mirror Biologics, Inc. 13
Not applicableUnknownNCT03732235
What this trial is testing

TACE Associated to Systemic Bevacizumab for the Treatment of Refractory Liver Metastases From Colorectal Cancer

Who this might be right for
Liver Metastasis Colon Cancer
Giammaria Fiorentini 50
Early research (Phase 1)Study completedNCT00496509
What this trial is testing

Phase I Efficacy On Vascular Permeability In Patients With Advanced Colorectal Cancer

Who this might be right for
Colorectal Cancer
Genzyme, a Sanofi Company 24
Not applicableUnknownNCT04213222
What this trial is testing

Radiomics Assess of Bevacizumab Plus Chemo in Colorectal Cancer Liver Metastases

Who this might be right for
Colon CancerRectal CancerLiver Metastases
Peking University People's Hospital 300
Large-scale testing (Phase 3)Study completedNCT00440310
What this trial is testing

Phase 3 Trial of Litx™ Plus Chemotherapy vs. Chemotherapy Only Treating Colorectal Cancer Patients With Recurrent Liver Metastases

Who this might be right for
Liver MetastasesColorectal NeoplasmsNeoplasm Metastasis+1 more
Light Sciences Oncology 483
Post-approval studies (Phase 4)Ended earlyNCT04973007
What this trial is testing

Comparison of Contrast Agents in Liver Magnetic Resonance (MR) for the Detection of Hepatic Metastases

Who this might be right for
Oligometastatic DiseaseLiver MetastasesColorectal Cancer
University of Colorado, Denver 10
Next Page